Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLitigation Cap. Regulatory News (LIT)

Share Price Information for Litigation Cap. (LIT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 113.00
Bid: 112.00
Ask: 113.50
Change: 0.75 (0.67%)
Spread: 1.50 (1.339%)
Open: 113.00
High: 113.00
Low: 111.50
Prev. Close: 112.00
LIT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Market Update

8 Jul 2022 07:00

RNS Number : 7671R
Litigation Capital Management Ltd
08 July 2022
 

8 July 2022

 

Litigation Capital Management Limited

(LCM or the Company)

 

Market Update

 

 

Litigation Capital Management Limited (AIM:LIT), a leading alternate asset manager of disputes financing solutions, provides a market update for the twelve month period to 30 June 2022 ("FY 2022").

 

Based on unaudited management accounts the Group expects to report positive growth in its financial performance compared to the comparative period covering the twelve months to 30 June 2021 ("FY 2021"), this is despite previously reported disruption and delay in justice systems. FY 2022 gross revenue is expected to be approximately 25% higher than FY 2021, with adjusted operating profit approximately 15% higher. Cash held at period end is A$29m and total assets under management increased to A$414m. A decrease in overall applications during the period reflected disrupted trading conditions, however commitments were broadly in line with the prior year, indicating progress on improving the quality of applications.

 

The Company had two material investments move into future financial periods. Whilst such delays are diminishing, they are still present in our portfolio. The financial performance of those investments will not be adversely impacted by the delay indeed it may be enhanced. As previously disclosed, this is purely a timing issue and is not an indication of LCM's current or future financial performance, nor should it be taken as a direct move of such cases into the following period forecasts as the collective portfolio and timing of resolutions is continually assessed based on how investments are progressing through either the court or arbitral cycle.

 

The degree of complexity in investments made by the Company means that whilst LCM has extensive experience in the provision of disputes funding and finance products to the market, that accurate forward forecasting is exceptionally difficult to achieve. It requires the financier to predict accurately when a particular investment, or portfolio of investments, will come to a conclusion either through a negotiated settlement of the dispute or an adjudication by a court or tribunal. Secondly, it requires the financier to predict the quantum of such a resolution, either as a negotiated settlement or as an award by the court or tribunal. Given the myriad of possible outcomes in respect of an investment in a dispute, it is not reasonable or responsible to provide market guidance.

 

Patrick Moloney, Chief Executive Officer, commented: "I'm pleased with our resilient performance for the second half of the financial year, despite continued challenging external conditions, in which we have maintained our level of commitments alongside growing our assets under management.

 

"Noting that the average life of these investments is historically 27 months, as our investments become larger and more complex, we expect the investment period to increase to between 36 and 42 months.

 

"With the current market instability and uncertainty, we remain very confident in LCM's growth prospects."

 

Enquiries

 

Litigation Capital Management

c/o Alma PR 

Patrick Moloney, Chief Executive Officer

 

 

 

 

Canaccord (Nomad and Joint Broker) 

Tel: 020 7523 8000

Bobbie Hilliam

Investec Bank plc (Joint Broker)

Tel: 020 7597 5970

David Anderson

 

Alma PR

Tel: 020 3405 0205

Justine James

Kieran Breheny

LCM@almapr.co.uk

 

 

NOTES TO EDITORS

 

Litigation Capital Management (LCM) is a global provider of disputes finance. LCM provides capital and risk management services into the disputes market including insolvency, commercial disputes, arbitral disputes, class actions and corporate portfolios.

LCM has an unparalleled track record, driven by effective project selection, active project management and robust risk management.

 

Current headquartered in Sydney, with offices in London, Singapore, Brisbane and Melbourne, LCM listed on AIM in December 2018, trading under the ticker LIT.

 

www.lcmfinance.com

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSSAESWEESESW
Date   Source Headline
23rd Aug 20227:00 amRNSNotice of Results
15th Jul 20228:22 amRNSDirector/PDMR Shareholding
8th Jul 20227:00 amRNSMarket Update
16th May 20227:00 amRNSLitigation Finance Agreement
4th May 202210:15 amRNSDirector/PDMR Shareholding
25th Apr 20229:30 amRNSDirector/PDMR Shareholding
11th Apr 202211:10 amRNSDirector/PDMR Shareholding
15th Mar 20227:00 amRNSInterim Results
14th Mar 202210:30 amRNSHolding(s) in Company
15th Feb 20227:00 amRNSNotice of Results
14th Feb 20227:00 amRNSMary Gangemi Appointed to the Board
7th Feb 202210:30 amRNSDirector/PDMR Shareholding
1st Feb 202212:45 pmRNSDirector/PDMR Shareholding
4th Jan 20223:58 pmRNSHolding(s) in Company
29th Dec 20214:10 pmRNSDirector/PDMR Shareholding
17th Dec 20217:00 amRNSBoard change
10th Dec 202112:30 pmRNSIssue of Equity and Total Voting Rights
18th Nov 20217:00 amRNSResult of AGM
4th Nov 20217:00 amRNSSuccessful Award in LCIA International Arbitration
29th Oct 20211:24 pmRNSExercise of Options, Equity Issue, Director/PDMR
29th Oct 20211:00 pmRNSIncentive Awards
25th Oct 20217:00 amRNSNotice of AGM
18th Oct 202111:15 amRNSIssue of Equity and Total Voting Rights
14th Oct 20217:00 amRNSLCM Global Alternative Returns Fund II
22nd Sep 202111:20 amRNSHolding(s) in Company
21st Sep 20217:00 amRNSFinal Results 2021
31st Aug 20217:00 amRNSNotice of Results
11th Aug 20217:07 amRNSSuccessful judgment in Australian investment
19th Jul 20217:00 amRNSMarket Update
6th Jul 20217:00 amRNSNew Litigation Finance Agreement
23rd Jun 20217:00 amRNSComet Group liquidation claim
21st Jun 20217:21 amRNSJudgment in New Zealand Investment
27th May 20217:00 amRNSInvestor Presentation
19th May 20217:18 amRNSLitigation Finance Agreement with Carillion
4th May 202112:09 pmRNSHolding(s) in Company
14th Apr 20214:41 pmRNSSecond Price Monitoring Extn
14th Apr 20214:36 pmRNSPrice Monitoring Extension
16th Mar 20217:00 amRNSInterim Results
10th Mar 20216:07 pmRNSIssue of Equity and Total Voting Rights
10th Mar 20215:53 pmRNSHolding(s) in Company
25th Feb 20217:00 amRNSRetail Investor Presentation
22nd Feb 20217:00 amRNSNew US$50m Credit Facility
18th Feb 20212:30 pmRNSHolding(s) in Company
17th Feb 20217:00 amRNSNotice of Results
12th Feb 20215:13 pmRNSHolding(s) in Company
7th Jan 202111:20 amRNSHolding(s) in Company
17th Dec 202012:17 pmRNSHolding(s) in Company
19th Nov 20207:00 amRNSResult of AGM
28th Oct 20207:00 amRNSNotice of Annual General Meeting
15th Oct 202010:30 amRNSIncentive Awards

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.